Tim Thurn News Today

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company, in partnership with C-RAD AB (NASDAQ Stockholm: CRAD B), will showcase an...

With an eye toward increasing its standard of patient care, the Iridium Network’s radiotherapy department adopted C-RAD’s Catalyst HD™ system, a solution that enables surface guided... | March 2, 2022

/PRNewswire/ -- C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed an agreement designed to enhance...

2021 Opens With Growth And Improved Profitability News provided by Share this article FIRST QUARTER 2021       Order intake amounted to 66.3 (47.7) MSEK, corresponding to a growth of 39% (49% in constant currencies). Order backlog amounted to 340.1 (261.5) MSEK Revenue amounted to 60.0 (51.8) MSEK, corresponding to a 16% growth (23% in constant currencies) Operating profit amounted to 6.2 (1.0) MSEK, corresponding to a margin of 10.4 (1.9) % Net results after tax amounted 3.2 (0.4) M...

A recording of the presentation will be made accessible on the C-RAD website after the presentation. About C-RAD C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patients motion during treatment to ensure high confidence, an e...

Share this article Share this article STOCKHOLM, April 23, 2021 /PRNewswire/ -- The Patent and Market Court of Appeal at the Svea Court of Appeal partly confirms the judgment of the Patent and Market Court of 26 July 2019, which gave C-RAD the right to the invention described in the patent application entitled "Ionizing radiation detecting device". The judgment from the Patent and Market Court of Appeal gives C-RAD the right to 50 percent of the invention as certain minor parts of the invention...

A recording of the presentation will be made accessible on the C-RAD website after the presentation. About C-RAD C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patients motion during treatment to ensure high confidence, an e...

Share this article STOCKHOLM, Feb. 22, 2021 /PRNewswire/ -- C-RAD and Alliance Radiation Oncology at Anna Jaques Hospital are proud to announce that Alliance has become the first center in the greater Northshore area to integrate C-RADs entire suite of surface tracking and workflow optimization products into their radiation therapy technology program. This new C-RAD installation will take Alliance Radiation Oncologys treatment delivery to the next level, increasing accuracy, enhancing patient...

Share this article Share this article STOCKHOLM, Feb. 3, 2021 /PRNewswire/ -- WITH-Global is a distribution mainly active in the field of diagnostic imaging and radiation therapy. With a team of 27 employees WITH-Global has a strong focus on providing services to its customers reaching from consulting to maintenance and hospital network services. WITH-Global has obtained the distribution rights for C-RADs positioning products and the HIT Laser systems. Mr Joo Il Dong, Managing Director of WITH-...

/PRNewswire/ -- FOURTH QUARTER 2020 Order intake increased 39% to 122.1 (88.1) MSEK (43% in constant currencies). Order backlog amounted to 350.5 (267.1) MSEK....